Cargando…

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis

INTRODUCTION: COVID-19 has spread with high morbidity and mortality worldwide. Many inactivated SARS-CoV-2 vaccines are being tested at various clinical trial stages for the control and prevention of COVID-19. We aim to comprehensively and objectively evaluate the safety and immunogenicity of inacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mao, Yang, Xuhong, Jiang, Lianyan, Yang, Dongdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573293/ https://www.ncbi.nlm.nih.gov/pubmed/34740936 http://dx.doi.org/10.1136/bmjopen-2021-056106

Ejemplares similares

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2023)

Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials
por: Voysey, Merryn, et al.
Publicado: (2016)

Nanosecond pulsed electric field (nsPEF) and vaccines: a novel technique for the inactivation of SARS-CoV-2 and other viruses?
por: Ruiz-Fernández, A. R., et al.
Publicado: (2022)

Predictors of hospitalization and severe disease due to breakthrough SARS‐CoV‐2 infection in fully vaccinated individuals
por: Johnson, Steven, et al.
Publicado: (2022)

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
por: Larivière, Ynke, et al.
Publicado: (2021)

Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case–control study
por: Khan, Unab Inayat, et al.
Publicado: (2023)

HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
por: Zaman, K, et al.
Publicado: (2020)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
por: Minassian, Angela M, et al.
Publicado: (2011)

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
por: Hitchon, Carol A, et al.
Publicado: (2023)

A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol
por: Xiao, Tiantian, et al.
Publicado: (2020)

Curating a knowledge base for individuals with coinfection of HIV and SARS-CoV-2: a study protocol of EHR-based data mining and clinical implementation
por: Liang, Chen, et al.
Publicado: (2022)

Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
por: Smit, Mikaela, et al.
Publicado: (2020)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
por: Green, C A, et al.
Publicado: (2015)

Vaccination reduces viral load and accelerates viral clearance in SARS-CoV-2 Delta variant-infected patients
por: Li, Hongxia, et al.
Publicado: (2023)

Quantifying the Individual Variation in Susceptibility to Endemic Coronavirus and SARS-CoV-2 with Human Challenge Trials
por: Miura, Fuminari, et al.
Publicado: (2023)

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021)

Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol
por: Guerriero, Massimo, et al.
Publicado: (2020)

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
por: Fernandes, Queenie, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination in Kidney Transplant Recipients—Stratified Analysis of the Humoral Immune Response
por: Lammert, Alexander, et al.
Publicado: (2022)

Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis
por: Singh, Surjit, et al.
Publicado: (2021)

CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
por: Chakravorty, Shourjo, et al.
Publicado: (2022)

SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study
por: Ray, Joel G, et al.
Publicado: (2022)

‘Reducing Delays In Vaccination’ (REDIVAC) trial: a protocol for a randomised controlled trial of a web-based, individually tailored, educational intervention to improve timeliness of infant vaccination
por: Dempsey, Amanda F, et al.
Publicado: (2019)

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study)
por: Mutubuki, Elizabeth N, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada
por: Zinszer, Kate, et al.
Publicado: (2021)

Masking by health care and public safety workers in non‐patient care areas to mitigate SARS‐CoV‐2 infection: A systematic review
por: Patterson, P. Daniel, et al.
Publicado: (2022)

Safety of Tdap vaccine in pregnant women: an observational study
por: Petousis-Harris, Helen, et al.
Publicado: (2016)

Radiographic findings of SARS‐CoV‐2 infection
por: Marco, Catherine A., et al.
Publicado: (2021)

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
por: Yahav, Dafna, et al.
Publicado: (2021)

Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season
por: Dos Santos, Gaël, et al.
Publicado: (2019)

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
por: Watson-Jones, Deborah, et al.
Publicado: (2022)

Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study
por: Mortgat, Laure, et al.
Publicado: (2021)

Safety and Efficacy of the COVID-19 Vaccine in Kidney Transplant Recipients
por: Altheaby, Abdulrahman, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
por: Price, Robert, et al.
Publicado: (2022)

Discordance Between SARS-CoV-2–specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2021)

VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients
por: Conrad, Anne, et al.
Publicado: (2019)

Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol
por: Perera, Marlon, et al.
Publicado: (2020)

Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
por: Deml, Ludwig, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fp6goks2kq38gag6l8t0v2pk4c